FdaApplication
NDA 215344
Identifiers
- fda_app_no: NDA215344
Properties
| Property | Value |
|---|---|
| applicant_name | AZURITY PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2023-06-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SUFLAVE | MAGNESIUM SULFATE; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM SULFATE | 0.9GM/BOT;178.7GM/BOT;1.12GM/BOT;0.5GM/BOT;7.3GM/BOT | FOR SOLUTION;ORAL |
1 product